Skip to content

Clinical trials

Gram-Positive Bacterial Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gram-Positive Bacterial Infections Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20034
20042
20055
20061
20071
20084
20092
20102
20112
20143
20163
20172
20184
20192
20201
20213
20221
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated10
Unknown status5
Withdrawn2
Not yet recruiting2
Recruiting2
Approved for marketing1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)6
Pfizer6
Cumberland Pharmaceuticals4
Wyeth is now a wholly owned subsidiary of Pfizer4
Michael Hoelscher2
Seres Therapeutics, Inc.2
Andrew Steer1
Basilea Pharmaceutica1
Biomedical Advanced Research and Development Authority1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gram-Positive Bacterial Infections57
Bacterial Infections20
Bacteremia9
Staphylococcal Infections7
Endocarditis5
Gram-Negative Bacterial Infections5
Sepsis5
Streptococcal Infections4
Wound Infection4
Abscess3

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.